7,899
Views
106
CrossRef citations to date
0
Altmetric
Review

Implications of laboratory diagnosis on brucellosis therapy

&
Pages 833-845 | Published online: 10 Jan 2014

References

  • Yagupsky P, Baron EJ. Laboratory exposures to brucellae and implications for bioterrorism. Emerg. Infect. Dis.11(8), 1180–1185 (2005).
  • Godfroid J, Cloeckaert A, Liautard JP et al. From the discovery of the Malta fever’s agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet. Res.36(3), 313–326 (2005).
  • Foster G, Osterman BS, Godfroid J, Jacques I, Cloeckaert A. Brucella ceti sp. nov. and Brucella pinnipedialis sp. nov. for Brucella strains with cetaceans and seals as their preferred hosts. Int. J. Syst. Evol. Microbiol.57(11), 2688–2693 (2007).
  • Scholz HC, Hubalek Z, Sedlácek I et al. Brucella microti sp. nov., isolated from the common vole Microtus arvalis. Int. J. Syst. Evol. Microbiol.58(2), 375–382 (2008).
  • Scholz HC, Hofer E, Vergnaud G et al. Isolation of Brucella microti from mandibular lymph nodes of red foxes, Vulpes vulpes, in lower Austria. Vector Borne Zoonotic Dis.9(2), 153–156 (2009).
  • Scholz HC, Hubalek Z, Nesvadbova J et al. Isolation of Brucella microti from soil. Emerg. Infect. Dis.14(8), 1316–1317 (2008).
  • Scholz HC, Nöckler K, Göllner C et al. Brucella inopinata sp. nov., isolated from a breast implant infection. Int. J. Syst. Evol. Microbiol.60(4), 801–808 (2010).
  • Tiller RV, Gee JE, Frace MA et al. Characterization of novel Brucella strains originating from wild native rodent species in North Queensland, Australia. Appl. Environ. Microbiol.76(17), 5837–5845 (2010).
  • Schlabritz-Loutsevitch NE, Whatmore AM, Quance CR et al. A novel Brucella isolate in association with two cases of stillbirth in non-human primates – first report. J. Med. Primatol.38(1), 70–73 (2009).
  • Tiller RV, Gee JE, Lonsway DR et al. Identification of an unusual Brucella strain (BO2) from a lung biopsy in a 52 year-old patient with chronic destructive pneumonia. BMC Microbiol.10, 23 (2010).
  • World Health Organization. Fact sheet N173. World Health Organization, Geneva, Switzerland (1997).
  • Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect. Dis.6(2), 91–99 (2006).
  • Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N. Engl. J. Med.352(22), 2325–2336 (2005).
  • Lucero NE, Ayala SM, Escobar GI, Jacob NR. Brucella isolated in humans and animals in Latin America from 1968 to 2006. Epidemiol. Infect.136(4), 496–503 (2008).
  • Refai M. Incidence and control of brucellosis in the Near East region. Vet. Microbiol.90(1–4), 81–110 (2002).
  • Wolfram JH, Butaev MK, Duysheev A et al. Brucellosis: a transboundary zoonotic disease. Epidemiology chapter. Vaccine28(Suppl. 5), F77–F84 (2010).
  • McDermott JJ, Arimi SM. Brucellosis in sub-Saharan Africa: epidemiology, control and impact. Vet. Microbiol.90(1–4), 111–134 (2002).
  • Taleski V, Zerva L, Kantardjiev T et al. An overview of the epidemiology and epizootology of brucellosis in selected countries of Central and Southeast Europe. Vet. Microbiol.90(1–4), 147–155 (2002).
  • Memish ZA, Balkhy HH. Brucellosis and international travel. J. Travel Med.11(1), 49–55 (2004).
  • Marcotty T, Matthys F, Godfroid J et al. Zoonotic tuberculosis and brucellosis in Africa: neglected zoonoses or minor public-health issues? The outcomes of a multi-disciplinary workshop. Ann. Trop. Med. Parasitol.103(5), 401–411 (2009).
  • Godfroid J, Käsbohrer A. Brucellosis in the European Union and Norway at the turn of the twenty-first century. Vet. Microbiol.90(1–4), 135–145 (2002).
  • Godfroid J. Brucellosis in wildlife. Rev. Sci. Tech.21(2), 277–286 (2002).
  • Gwida M, Al Dahouk S, Melzer F, Rösler U, Neubauer H, Tomaso H. Brucellosis – regionally emerging zoonotic disease? Croat. Med. J.51(4), 289–295 (2010).
  • Colmenero JD, Reguera JM, Martos F et al. Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine (Baltimore) 75(4), 195–211 (1996).
  • Buzgan T, Karahocagil MK, Irmak H et al. Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature. Int. J. Infect. Dis.14(6), e469–e478 (2010).
  • Al Dahouk S, Neubauer H, Hensel A et al. Changing epidemiology of human brucellosis, Germany, 1962–2005. Emerg. Infect. Dis.13(12), 1895–1900 (2007).
  • Ariza J, Bosilkovski M, Cascio A et al.; International Society of Chemotherapy; Institute of Continuing Medical Education of Ioannina. Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med.4(12), e317 (2007).
  • Corbel MJ. Treatment of human brucellosis. In: Brucellosis in Humans and Animals (Chapter 5). Corbel MJ, Elberg SS, Cosivi O (Eds). World Health Organization, Geneva, Switzerland, 36–41 (2006).
  • Skalsky K, Yahav D, Bishara J, Pitlik S, Leibovici L, Paul M. Treatment of human brucellosis: systematic review and meta-analysis of randomised controlled trials. BMJ336(7646), 701–704 (2008).
  • Solera J. Update on brucellosis: therapeutic challenges. Int. J. Antimicrob. Agents36(Suppl. 1), S18–S20 (2010).
  • Al Dahouk S, Tomaso H, Nöckler K, Neubauer H, Frangoulidis D. Laboratory-based diagnosis of brucellosis – a review of the literature. Part I: techniques for direct detection and identification of Brucella spp. Clin. Lab.49(9–10), 487–505 (2003).
  • Yagupsky P. Detection of brucellae in blood cultures. J. Clin. Microbiol.37(11), 3437–3442 (1999).
  • Memish Z, Mah MW, Al Mahmoud S, Al Shaalan M, Khan MY. Brucella bacteraemia: clinical and laboratory observations in 160 patients. J. Infect.40(1), 59–63 (2000).
  • Kadanali A, Ozden K, Altoparlak U, Erturk A, Parlak M. Bacteremic and nonbacteremic brucellosis: clinical and laboratory observations. Infection37(1), 67–69 (2009).
  • Espinosa BJ, Chacaltana J, Mulder M et al. Comparison of culture techniques at different stages of brucellosis. Am. J. Trop. Med. Hyg.80(4), 625–627 (2009).
  • Franco MP, Mulder M, Gilman RH, Smits HL. Human brucellosis. Lancet Infect. Dis.7(12), 775–786 (2007).
  • Gotuzzo E, Carrillo C, Guerra J, Llosa L. An evaluation of diagnostic methods for brucellosis – the value of bone marrow culture. J. Infect. Dis.153(1), 122–125 (1986).
  • Mantur BG, Mulimani MS, Bidari LH, Akki AS, Tikare NV. Bacteremia is as unpredictable as clinical manifestations in human brucellosis. Int. J. Infect. Dis.12(3), 303–307 (2008).
  • Baysallar M, Aydogan H, Kilic A, Kucukkaraaslan A, Senses Z, Doganci L. Evaluation of the BacT/ALERT and BACTEC 9240 automated blood culture systems for growth time of Brucella species in a Turkish tertiary hospital. Med. Sci. Monit.12(7), BR235–BR238 (2006).
  • Cetin ES, Kaya S, Demirci M, Aridogan BC. Comparison of the BACTEC blood culture system versus conventional methods for culture of normally sterile body fluids. Adv. Ther.24(6), 1271–1277 (2007).
  • Mantur BG, Bidari LH, Akki AS, Mulimani MS, Tikare NV. Diagnostic yield of blood clot culture in the accurate diagnosis of enteric fever and human brucellosis. Clin. Lab.53(1–2), 57–61 (2007).
  • Mantur BG, Mangalgi SS. Evaluation of conventional Castañeda and lysis centrifugation blood culture techniques for diagnosis of human brucellosis. J. Clin. Microbiol.42(9), 4327–4328 (2004).
  • Yagupsky P. Use of the BACTEC Myco/F Lytic medium for detection of Brucella melitensis bacteremia. J. Clin. Microbiol.42(5), 2207–2208 (2004).
  • Rovery C, Rolain JM, Raoult D, Brouqui P. Shell vial culture as a tool for isolation of Brucella melitensis in chronic hepatic abscess. J. Clin. Microbiol.41(9), 4460–4461 (2003).
  • Alton GG, Jones LM, Angus RD, Verger JM. Techniques for the Brucellosis Laboratory. Institut National de la Recherche Agronomique, Paris, France (1988).
  • Barham WB, Church P, Brown JE, Paparello S. Misidentification of Brucella species with use of rapid bacterial identification systems. Clin. Infect. Dis.17(6), 1068–1069 (1993).
  • Elsaghir AA, James EA. Misidentification of Brucella melitensis as Ochrobactrum anthropi by API 20 NE. J. Med. Microbiol.52(5), 441–442 (2003).
  • Al Dahouk S, Scholz HC, Tomaso H et al. Differential phenotyping of Brucella species using a newly developed semi-automated metabolic system. BMC Microbiol.10, 269 (2010).
  • Rich M, Bannatyne RM, Memish ZA. Direct urease test on BACTEC blood cultures: early presumptive diagnosis of brucellosis in an area of endemicity. J. Clin. Microbiol.38(4), 1706 (2000).
  • Rich M, Memish ZA. Presumptive diagnosis of brucellosis from contaminated blood cultures in an area of endemicity. Br. J. Biomed. Sci.61(2), 93–94 (2004).
  • Wellinghausen N, Nöckler K, Sigge A, Bartel M, Essig A, Poppert S. Rapid detection of Brucella spp. in blood cultures by fluorescence in situ hybridization. J. Clin. Microbiol.44(5), 1828–1830 (2006).
  • Qu Q, Zhu Z, Wang Y et al. Rapid and quantitative detection of Brucella by up-converting phosphor technology-based lateral-flow assay. J. Microbiol. Methods79(1), 121–123 (2009).
  • Al Dahouk S, Nöckler K, Scholz HC, Tomaso H, Bogumil R, Neubauer H. Immunoproteomic characterization of Brucella abortus 1119-3 preparations used for the serodiagnosis of Brucella infections. J. Immunol. Methods309(1–2), 34–47 (2006).
  • Ferreira L, Vega Castaño S, Sánchez-Juanes F et al. Identification of Brucella by MALDI-TOF mass spectrometry. Fast and reliable identification from agar plates and blood cultures. PLoS ONE5(12), e14235 (2010).
  • Ariza J, Bosch J, Gudiol F, Liñares J, Viladrich PF, Martín R. Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis. Antimicrob. Agents Chemother.30(6), 958–960 (1986).
  • Al Dahouk S, Tomaso H, Nöckler K, Neubauer H, Frangoulidis D. Laboratory-based diagnosis of brucellosis – a review of the literature. Part II: serological tests for brucellosis. Clin. Lab.49(11–12), 577–589 (2003).
  • Ariza J, Pellicer T, Pallarés R, Foz A, Gudiol F. Specific antibody profile in human brucellosis. Clin. Infect. Dis.14(1), 131–140 (1992).
  • Casanova A, Ariza J, Rubio M, Masuet C, Díaz R. Brucellacapt versus classical tests in the serological diagnosis and management of human brucellosis. Clin. Vaccine Immunol.16(6), 844–851 (2009).
  • Bosilkovski M, Katerina S, Zaklina S, Ivan V. The role of Brucellacapt test for follow-up patients with brucellosis. Comp. Immunol. Microbiol. Infect. Dis.33(5), 435–442 (2010).
  • Lucero NE, Escobar GI, Ayala SM, Jacob N. Diagnosis of human brucellosis caused by Brucella canis. J. Med. Microbiol.54(5), 457–461 (2005).
  • Araj GF. Update on laboratory diagnosis of human brucellosis. Int. J. Antimicrob. Agents36(Suppl. 1), 12–17 (2010).
  • Konstantinidis A, Minas A, Pournaras S et al. Evaluation and comparison of fluorescence polarization assay with three of the currently used serological tests in diagnosis of human brucellosis. Eur. J. Clin. Microbiol. Infect. Dis.26(10), 715–721 (2007).
  • Lucero NE, Escobar GI, Ayala SM, Silva Paulo P, Nielsen K. Fluorescence polarization assay for diagnosis of human brucellosis. J. Med. Microbiol.52(10), 883–887 (2003).
  • Ruiz-Mesa JD, Sánchez-Gonzalez J, Reguera JM, Martín L, Lopez-Palmero S, Colmenero JD. Rose Bengal test: diagnostic yield and use for the rapid diagnosis of human brucellosis in emergency departments in endemic areas. Clin. Microbiol. Infect.11(3), 221–225 (2005).
  • Sharma R, Chisnall C, Cooke RP. Evaluation of in-house and commercial immunoassays for the sero-diagnosis of brucellosis in a non-endemic low prevalence population. J. Infect.56(2), 108–113 (2008).
  • Zeytinoğlu A, Turhan A, Altuğlu I, Bilgiç A, Abdoel TH, Smits HL. Comparison of Brucella immunoglobulin M and G flow assays with serum agglutination and 2-mercaptoethanol tests in the diagnosis of brucellosis. Clin. Chem. Lab. Med.44(2), 180–184 (2006).
  • Mantur B, Parande A, Amarnath S et al. ELISA versus conventional methods of diagnosing endemic brucellosis. Am. J. Trop. Med. Hyg.83(2), 314–318 (2010).
  • Gómez MC, Nieto JA, Rosa C et al. Evaluation of seven tests for diagnosis of human brucellosis in an area where the disease is endemic. Clin. Vaccine Immunol.15(6), 1031–1033 (2008).
  • Roushan MR, Amiri MJ, Laly A, Mostafazadeh A, Bijani A. Follow-up standard agglutination and 2-mercaptoethanol tests in 175 clinically cured cases of human brucellosis. Int. J. Infect. Dis.14(3), e250–e253 (2010).
  • Araj GF, Kattar MM, Fattouh LG, Bajakian KO, Kobeissi SA. Evaluation of the PANBIO Brucella immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays for diagnosis of human brucellosis. Clin. Diagn. Lab. Immunol.12(11), 1334–1335 (2005).
  • Prince HE, Lopez J, Yeh C et al. Performance characteristics of the Euroimmun enzyme-linked immunosorbent assay kits for Brucella IgG and IgM. Diagn. Microbiol. Infect. Dis.65(2), 99–102 (2009).
  • Díaz R, Ariza J, Alberola I, Casanova A, Rubio MF. Secondary serological response of patients with chronic hepatosplenic suppurative brucellosis. Clin. Vaccine Immunol.13(11), 1190–1196 (2006).
  • Cakan G, Bezirci FB, Kacka A et al. Assessment of diagnostic enzyme-linked immunosorbent assay kit and serological markers in human brucellosis. Jpn. J. Infect. Dis.61(5), 366–370 (2008).
  • Al Dahouk S, Neubauer H, Tomaso H. Brucella. In: Molecular Detection of Human Bacterial Pathogens (Chapter 54). Liu D (Ed.). Taylor & Francis CRC Press, Boca Raton, FL, USA, 629–646 (2011).
  • Navarro E, Casao MA, Solera J. Diagnosis of human brucellosis using PCR. Expert Rev. Mol. Diagn.4(1), 115–123 (2004).
  • Colmenero JD, Morata P, Ruiz-Mesa JD et al. Multiplex real-time polymerase chain reaction: a practical approach for rapid diagnosis of tuberculous and brucellar vertebral osteomyelitis. Spine35(24), 1392–1396 (2010).
  • Colmenero JD, Queipo-Ortuño MI, Reguera JM, Baeza G, Salazar JA, Morata P. Real time polymerase chain reaction: a new powerful tool for the diagnosis of neurobrucellosis. J. Neurol. Neurosurg. Psychiatry76(7), 1025–1027 (2005).
  • Debeaumont C, Falconnet PA, Maurin M. Real-time PCR for detection of Brucella spp. DNA in human serum samples. Eur. J. Clin. Microbiol. Infect. Dis.24(12), 842–845 (2005).
  • Queipo-Ortuño MI, Colmenero JD, Bermudez P, Bravo MJ, Morata P. Rapid differential diagnosis between extrapulmonary tuberculosis and focal complications of brucellosis using a multiplex real-time PCR assay. PLoS ONE4(2), e4526 (2009).
  • Queipo-Ortuño MI, Colmenero JD, Muñoz N, Baeza G, Clavijo E, Morata P. Rapid diagnosis of Brucella epididymo-orchitis by real-time polymerase chain reaction assay in urine samples. J. Urol.176(5), 2290–2293 (2006).
  • Queipo-Ortuño MI, Colmenero JD, Reguera JM et al. Rapid diagnosis of human brucellosis by SYBR Green I-based real-time PCR assay and melting curve analysis in serum samples. Clin. Microbiol. Infect.11(9), 713–718 (2005).
  • Mitka S, Anetakis C, Souliou E, Diza E, Kansouzidou A. Evaluation of different PCR assays for early detection of acute and relapsing brucellosis in humans in comparison with conventional methods. J. Clin. Microbiol.45(4), 1211–1218 (2007).
  • Zerva L, Bourantas K, Mitka S, Kansouzidou A, Legakis NJ. Serum is the preferred clinical specimen for diagnosis of human brucellosis by PCR. J. Clin. Microbiol.39(4), 1661–1664 (2001).
  • Baily GG, Krahn JB, Drasar BS, Stoker NG. Detection of Brucella melitensis and Brucella abortus by DNA amplification. J. Trop. Med. Hyg.95(4), 271–275 (1992).
  • Al Dahouk S, Nöckler K, Scholz HC, Pfeffer M, Neubauer H, Tomaso H. Evaluation of genus-specific and species-specific real-time PCR assays for the identification of Brucella spp. Clin. Chem. Lab. Med.45(11), 1464–1470 (2007).
  • Gee JE, De BK, Levett PN, Whitney AM, Novak RT, Popovic T. Use of 16S rRNA gene sequencing for rapid confirmatory identification of Brucella isolates. J. Clin. Microbiol.42(8), 3649–3654 (2004).
  • García-Yoldi D, Marín CM, de Miguel MJ, Muñoz PM, Vizmanos JL, López-Goñi I. Multiplex PCR assay for the identification and differentiation of all Brucella species and the vaccine strains Brucella abortus S19 and RB51 and Brucella melitensis Rev1. Clin. Chem.52(4), 779–781 (2006).
  • Mayer-Scholl A, Draeger A, Göllner C, Scholz HC, Nöckler K. Advancement of a multiplex PCR for the differentiation of all currently described Brucella species. J. Microbiol. Methods80(1), 112–114 (2010).
  • López-Goñi I, García-Yoldi D, Marín CM et al. Evaluation of a multiplex PCR assay (Bruce-ladder) for molecular typing of all Brucella species, including the vaccine strains. J. Clin. Microbiol.46(10), 3484–3487 (2008).
  • Al Dahouk S, Tomaso H, Nöckler K, Neubauer H. The detection of Brucella spp. using PCR-ELISA and real-time PCR assays. Clin. Lab.50(7–8), 387–394 (2004).
  • Queipo-Ortuño MI, Colmenero JD, Macias M, Bravo MJ, Morata P. Preparation of bacterial DNA template by boiling and effect of immunoglobulin G as an inhibitor in real-time PCR for serum samples from patients with brucellosis. Clin. Vaccine Immunol.15(2), 293–296 (2008).
  • Maas KS, Méndez M, Zavaleta M et al. Evaluation of brucellosis by PCR and persistence after treatment in patients returning to the hospital for follow-up. Am. J. Trop. Med. Hyg.76(4), 698–702 (2007).
  • Queipo-Ortuño MI, Tena F, Colmenero JD, Morata P. Comparison of seven commercial DNA extraction kits for the recovery of Brucella DNA from spiked human serum samples using real-time PCR. Eur. J. Clin. Microbiol. Infect. Dis.27(2), 109–114 (2008).
  • Vrioni G, Pappas G, Priavali E, Gartzonika C, Levidiotou S. An eternal microbe: Brucella DNA load persists for years after clinical cure. Clin. Infect. Dis.46(12), 131–136 (2008).
  • Navarro E, Segura JC, Castaño MJ, Solera J. Use of real-time quantitative polymerase chain reaction to monitor the evolution of Brucella melitensis DNA load during therapy and post-therapy follow-up in patients with brucellosis. Clin. Infect. Dis.42(9), 1266–1273 (2006).
  • Bounaadja L, Albert D, Chénais B et al. Real-time PCR for identification of Brucella spp.: a comparative study of IS711, bcsp31 and per target genes. Vet. Microbiol.137(1–2), 156–164 (2009).
  • Hinić V, Brodard I, Thomann A et al. Novel identification and differentiation of Brucella melitensis, B. abortus, B. suis, B. ovis, B. canis, and B. neotomae suitable for both conventional and real-time PCR systems. J. Microbiol. Methods75(2), 375–378 (2008).
  • Castaño MJ, Solera J. Chronic brucellosis and persistence of Brucella melitensis DNA. J. Clin. Microbiol.47(7), 2084–2089 (2009).
  • Queipo-Ortuño MI, Colmenero JD, Bravo MJ, García-Ordoñez MA, Morata P. Usefulness of a quantitative real-time PCR assay using serum samples to discriminate between inactive, serologically positive and active human brucellosis. Clin. Microbiol. Infect.14(12), 1128–1134 (2008).
  • Morata P, Queipo-Ortuño MI, Reguera JM, García-Ordoñez MA, Pichardo C, Colmenero JD. Posttreatment follow-up of brucellosis by PCR assay. J. Clin. Microbiol.37(12), 4163–4166 (1999).
  • Le Flèche P, Jacques I, Grayon M et al. Evaluation and selection of tandem repeat loci for a Brucella MLVA typing assay. BMC Microbiol.6, 9 (2006).
  • Whatmore AM, Shankster SJ, Perrett LL et al. Identification and characterization of variable-number tandem-repeat markers for typing of Brucella spp. J. Clin. Microbiol.44(6), 1982–1993 (2006).
  • Al Dahouk S, Le Flèche P, Nöckler K et al. Evaluation of Brucella MLVA typing for human brucellosis. J. Microbiol. Methods69(1), 137–145 (2007).
  • Al Dahouk S, Hagen RM, Nöckler K et al. Failure of a short-term antibiotic therapy for human brucellosis using ciprofloxacin. A study on in vitro susceptibility of Brucella strains. Chemotherapy51(6), 352–356 (2005).
  • Young EJ. Human brucellosis. Rev. Infect. Dis.5(5), 821–842 (1983).
  • Özkurt Z, Erol S, Tasyaran MA, Kaya A. Detection of Brucella melitensis by the BacT/Alert automated system and Brucella broth culture. Clin. Microbiol. Infect.8(11), 749–752 (2002).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.